WMCWeill Medical College of Cornell University · Microbiology & Immunology
Innovative Therapeutics Lab
Gang Lin · New York, New York
Research Focus
Dr. Gang Lin's research lab focuses on developing innovative proteasome inhibitors to treat aggressive cancers like triple negative breast cancer and to combat drug-resistant malaria. By understanding protein degradation mechanisms in cells, his team aims to create safer and more effective therapeutics that can address significant health challenges in both oncology and infectious diseases.
proteasome inhibitorstriple negative breast cancermalariaPlasmodiumdrug resistance
Research Aims
3AIM 01Develop novel proteasome inhibitors targeting beta2 and beta5 subunits for breast cancer treatment.
AIM 02Create multi-stage antimalarial drugs targeting Plasmodium proteasome.
AIM 03Evaluate the effectiveness of new proteasome inhibitors in animal models.
Skills the Lab Values
cell cultureanimal modelsstructure-activity relationship (SAR) studiesWestern blotpharmacokinetic studies
Output against the department
Publications90bottom 30% of dept.339th of 486
this lab
most publishedleast published
Citations2.7kbottom 17% of dept.404th of 486
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.